REGN Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors Class Action Against Regeneron Pharmaceuticals, Inc.
13. Januar 2025 21:48 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Regeneron Pharmaceuticals, Inc. (REGN) Misled Investors Regarding its Business Prospects
MGP Ingredients, Inc. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the MGPI Class Action
13. Januar 2025 21:23 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that MGP Ingredients, Inc. (MGPI) Misled Investors Regarding Demand and Inventory Levels
Transocean Ltd. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the RIG Class Action
13. Januar 2025 21:21 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Transocean Ltd. (RIG) Misled Investors Regarding its Business Prospect
Stockholder Notice: Robbins LLP Informs Stockholders of the Micron Technology, Inc. Class Action Lawsuit
13. Januar 2025 21:07 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Micron Technology, Inc. (MU) Failed to Disclose Decreased Demand for its Products.
DMC Global Inc. Shareholder are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the BOOM Class Action
13. Januar 2025 20:50 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that DMC Global Inc. (BOOM) Misled Investors Regarding its Operations and Financial Results
Caribou Biosciences, Inc. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the CRBU Class Action
13. Januar 2025 20:42 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Caribou Biosciences, Inc. (CRBU) Misled Investors Regarding the Efficacy of its Lead Drug Candidate
BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against BioAge Labs, Inc.
13. Januar 2025 20:39 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
Capri Holdings Limited Shareholders are Encouraged to Contact Robbins LLP for Information About the CPRI Class Action
13. Januar 2025 20:33 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Capri Holdings Limited (CPRI) Misled Investors Regarding the Viability of its Acquisition by Tapestry, Inc.
AZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class Action
13. Januar 2025 19:49 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that AstraZeneca PLC (AZN) Misled Investors Regarding its Legal Exposure in China
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
08. Januar 2025 18:46 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO